A structural mean model to allow for noncompliance in a randomized trial comparing 2 active treatments
Open Access
- 30 August 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Biostatistics
- Vol. 12 (2), 247-257
- https://doi.org/10.1093/biostatistics/kxq053
Abstract
We propose a structural mean modeling approach to obtain compliance-adjusted estimates for treatment effects in a randomized-controlled trial comparing 2 active treatments. The model relates an individual's observed outcome to his or her counterfactual untreated outcome through the observed receipt of active treatments. Our proposed estimation procedure exploits baseline covariates that predict compliance levels on each arm. We give a closed-form estimator which allows for differential and unexplained selectivity (i.e. noncausal compliance-outcome association due to unobserved confounding) as well as a nonparametric error distribution. In a simple linear model for a 2-arm trial, we show that the distinct causal parameters are identified unless covariate-specific expected compliance levels are proportional on both treatment arms. In the latter case, only a linear contrast between the 2 treatment effects is estimable and may well be of key interest. We demonstrate the method in a clinical trial comparing 2 antidepressants.Keywords
This publication has 21 references indexed in Scilit:
- Estimating dose-response effects in psychological treatment trials: the role of instrumental variablesStatistical Methods in Medical Research, 2008
- Six-month compliance with antidepressant medication in the treatment of major depressive disorderInternational Clinical Psychopharmacology, 2008
- Principal stratification with predictors of compliance for randomized trials with 2 active treatmentsBiostatistics, 2007
- Small-sample degrees of freedom for multi-component significance tests with multiple imputation for missing dataBiometrika, 2007
- Estimating psychological treatment effects from a randomised controlled trial with both non-compliance and loss to follow-upThe British Journal of Psychiatry, 2003
- The price of innovation: new estimates of drug development costsJournal of Health Economics, 2003
- The Effect of Treatment Compliance in a Placebo-Controlled Trial: Regression with Unpaired DataJournal of the Royal Statistical Society Series C: Applied Statistics, 1997
- Estimation of Regression Coefficients When Some Regressors are not Always ObservedJournal of the American Statistical Association, 1994
- Correcting for non-compliance in randomized trials using structural nested mean modelsCommunications in Statistics - Theory and Methods, 1994
- Compliance as an Explanatory Variable in Clinical TrialsJournal of the American Statistical Association, 1991